MLPA results obtained on a group of 60 breast cancer patients were compared with those provided by immunohistochemistry (IHC), showing a good correlation between HER-2/neu gene amplification detected by MLPA and overexpression by IHC in invasive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.